Plasma 25-Hydroxyvitamin D Concentration and Metabolic Syndrome Among Middle-Aged and Elderly Chinese Individuals
Open Access
- 14 April 2009
- journal article
- research article
- Published by American Diabetes Association in Diabetes Care
- Vol. 32 (7), 1278-1283
- https://doi.org/10.2337/dc09-0209
Abstract
OBJECTIVE: To evaluate the association between 25-hydroxyvitamin D [25(OH)D] and metabolic syndrome in the Chinese population. RESEARCH DESIGN AND METHODS: Plasma 25(OH)D was measured in a cross-sectional sample of 1,443 men and 1,819 women aged 50–70 years from Beijing and Shanghai. Metabolic syndrome was defined according to the updated National Cholesterol Education Program Adult Treatment Panel III criteria for Asian Americans. Fasting plasma glucose, insulin, lipid profile, A1C, and inflammatory markers were measured. RESULTS: The geometric mean of plasma 25(OH)D was 40.4 nmol/l, and percentages of vitamin D deficiency [25(OH)D <50 nmol/l] and insufficiency [50 ≤ 25(OH)D <75 nmol/l] were 69.2 and 24.4%, respectively. Compared with the highest 25(OH)D quintile (≥57.7 nmol/l), the odds ratio for metabolic syndrome in the lowest quintile (≤28.7 nmol/l) was 1.52 (95% CI 1.17–1.98, Ptrend = 0.0002) after multiple adjustment. Significant inverse associations also existed between 25(OH)D and individual metabolic syndrome components plus A1C. Moreover, we observed significant inverse associations of 25(OH)D with fasting insulin and the insulin resistance index (homeostasis model assessment of insulin resistance [HOMA-IR]) in overweight and obese individuals (BMI ≥24 kg/m2) but not in their normal-weight counterparts (test for interaction: P = 0.0363 and 0.0187 for insulin and HOMA-IR, respectively). CONCLUSIONS: Vitamin D deficiency is common in the middle-aged and elderly Chinese population, and a low 25(OH)D level is significantly associated with an increased risk of having metabolic syndrome and insulin resistance. Prospective studies and randomized clinical trials are warranted to determine the role of 25(OH)D in the development of metabolic syndrome and related metabolic diseases.Keywords
This publication has 26 references indexed in Scilit:
- Parathyroid hormone, but not vitamin D, is associated with the metabolic syndrome in morbidly obese women and men: a cross-sectional studyCardiovascular Diabetology, 2009
- Baseline Serum 25-Hydroxy Vitamin D Is Predictive of Future Glycemic Status and Insulin ResistanceDiabetes, 2008
- 1,25‐Dihydroxyvitamin D improved the free fatty‐acid‐induced insulin resistance in cultured C2C12 cellsDiabetes/Metabolism Research and Reviews, 2008
- Advances in Male ContraceptionEndocrine Reviews, 2008
- The vitamin D receptor geneBsmI polymorphism is not associated with anthropometric and biochemical parameters describing metabolic syndrome in postmenopausal womenGynecological Endocrinology, 2008
- Vitamin D deficiency is associated with the metabolic syndrome in morbid obesityClinical Nutrition, 2007
- Vitamin D DeficiencyThe New England Journal of Medicine, 2007
- The Role of Vitamin D and Calcium in Type 2 Diabetes. A Systematic Review and Meta-AnalysisJournal of Clinical Endocrinology & Metabolism, 2007
- Diagnosis and Management of the Metabolic SyndromeCirculation, 2005
- AGE, VITAMIN D, AND SOLAR ULTRAVIOLETThe Lancet, 1989